跳转至内容
Merck
CN
所有图片(1)

主要文件

A1320000

阿司帕坦

European Pharmacopoeia (EP) Reference Standard

别名:

天冬酰-苯丙氨酸甲酯, N-(L-α-天冬氨酰)- L -苯丙氨酸甲酯, 天冬甜素, 阿斯巴甜

登录查看公司和协议定价

选择尺寸

40 MG
¥1,286.84

¥1,286.84


请联系客服了解存货情况

获取大包装报价

选择尺寸

变更视图
40 MG
¥1,286.84

About This Item

线性分子式:
HOOCCH2CH(NH2)CONHCH(CH2C6H5)COOCH3
CAS Number:
分子量:
294.30
Beilstein:
2223850
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24

¥1,286.84


请联系客服了解存货情况

获取大包装报价

等级

pharmaceutical primary standard

Agency

EP Reference Standard

API类

aspartame

制造商/商品名称

EDQM

应用

pharmaceutical (small molecule)

包装形式

neat

储存温度

2-8°C

SMILES字符串

COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O

InChI

1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1

InChI key

IAOZJIPTCAWIRG-QWRGUYRKSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Aspartame EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

储存分类代码

11 - Combustible Solids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


  • 历史批次信息供参考:

    分析证书(COA)

    Lot/Batch Number

    It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

    如需帮助,请联系 客户支持

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Eva S Schernhammer et al.
    The American journal of clinical nutrition, 96(6), 1419-1428 (2012-10-26)
    Despite safety reports of the artificial sweetener aspartame, health-related concerns remain. We prospectively evaluated whether the consumption of aspartame- and sugar-containing soda is associated with risk of hematopoetic cancers. We repeatedly assessed diet in the Nurses' Health Study (NHS) and
    Jean-Daniel Berset et al.
    Chemosphere, 88(5), 563-569 (2012-04-17)
    A HPLC-MS/MS method is presented for the simultaneous determination of frequently used artificial sweeteners (ASs) and the main metabolite of aspartame (ASP), diketopiperazine (DKP), in environmental water samples using the direct-injection (DI) technique, thereby achieving limits of quantification (LOQ) of
    Maria Maersk et al.
    The American journal of clinical nutrition, 95(2), 283-289 (2011-12-30)
    The consumption of sucrose-sweetened soft drinks (SSSDs) has been associated with obesity, the metabolic syndrome, and cardiovascular disorders in observational and short-term intervention studies. Too few long-term intervention studies in humans have examined the effects of soft drinks. We compared
    M Maersk et al.
    European journal of clinical nutrition, 66(4), 523-529 (2012-01-19)
    Observational studies indicate that sugar-sweetened soft drinks (SSSD) may promote obesity, among other factors, owing to low-satiating effects. The effect of energy in drinks on appetite is still unclear. We examined the effect of two isocaloric, but macronutrient, different beverages
    Maartje C P Geraedts et al.
    Molecular nutrition & food research, 56(3), 417-424 (2012-03-02)
    Exposing the intestine to proteins or tastants, particularly sweet, affects satiety hormone release. There are indications that each sweetener has different effects on this release, and that combining sweeteners with other nutrients might exert synergistic effects on hormone release. STC-1

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持